NEM Glucosamine Hydrochloride
Natural health product licensed in Canada
- Other names
- 750 mg Glucosamine Hydrochloride and Eggshell, Glucosamine Hydrochloride, Glucosamine Hydrochloride and Eggshell, NEM & Vegetarian Glucosamine Hydrochloride, NEM Glucosamine HCL, NEM Vegetarian Glucosamine Hydrochloride, Super NEM Glucosamine Hydrochloride, Super NEM Vegetarian Glucosamine Hydrochloride, Vegetarian Glucosamine Hydrochloride and Eggshell
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80145820
- Status
- Active licence
- Licence date
- 2 December 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 750 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf | 250 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Partially hydrolysed chicken eggshell membrane | 250 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Croscarmellose de sodium, Acide stéarique, Hydroxypropylcellulose, NA, Méthylcellulose, Silice, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps maintain healthy cartilage/joint health. Helps relieve joint pain due to osteoarthritis and a factor in maintaining healthy cartilage. Clinically proven to help reduce joint pain in 7-10 days. Helps to reduce joint pain and stiffness. Helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women. Increases joint flexibility. Helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). Starts to reduce joint pain due to moderate intensity aerobic exercises in as little /as quickly as 1 day and joint stiffness in as little /as quickly as 5 days. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. Helps reduce joint stiffness associated with osteoarthritis. Research-proven to help reduce joint pain in 7-10 days. Starts to help reduce pain and increase joint flexibility at 7 days. Helps relieve joint pain in 7-10 days.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80145820
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.